4//SEC Filing
Ebbers Ed 4
Accession 0001209191-21-022927
CIK 0001625101other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 6:17 PM ET
Size
8.0 KB
Accession
0001209191-21-022927
Insider Transaction Report
Form 4
Ebbers Ed
EVP & GM, Dermatology
Transactions
- Award
Stock Option (right to buy)
2021-02-23+37,500→ 37,500 totalExercise: $10.66Exp: 2030-05-18→ Common Stock (37,500 underlying) - Award
Stock Option (right to buy)
2021-03-22+15,875→ 15,875 totalExercise: $24.03From: 2022-03-01Exp: 2031-03-22→ Common Stock (15,875 underlying)
Footnotes (2)
- [F1]Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020.
- [F2]The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of March 1, 2021, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Pulse Biosciences, Inc.
CIK 0001625101
Entity typeother
Related Parties
1- filerCIK 0001643353
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 6:17 PM ET
- Size
- 8.0 KB